Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Engcan77on Jun 17, 2019 12:24am

80 Views

Post# 29831015

RE:RE:My Video Chart Breakdown of Sirona Biochem

hcdtrading. I appreciate your input. I know what you are saying. If a deal, or some good news about the progress doesn't come soon. Or Howard doesn't give us some info at the Agm that everything is on plan, then yes we could see a bit of a slide. However, most of us are here for the long run. Back in 2011, Sirona was not in the place it is now, so cannot really compare. Anyway, like you said...time will tell.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec